TY - JOUR
T1 - The role of the comprehensive geriatric assessment in the evaluation of the older cancer patient
AU - Blanquicett, Carmelo
AU - Cohen, Jonathon B.
AU - Flowers, Christopher
AU - Johnson, Theodore
N1 - Publisher Copyright:
© 2019 UBM Medica Healthcare Publications. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2019
Y1 - 2019
N2 - Geriatric assessments have now been recommended as part of the standard evaluation of an older adult considering cancer therapy. While the need for a more in-depth performance status evaluation of an older person with cancer was identified over 20 years ago, completion of a comprehensive geriatric assessment (CGA) is time-consuming and not frequently performed as part of the standard assessment of older cancer patients. Evidence suggests that incorporating such an evaluation could be useful for potentially determining the patient's chemotherapy tolerability or treatment completion, toxicity, and survival, as age alone has been shown to poorly predict treatment failure, and performance status assessments commonly used in oncology practice may lack predictability. This review describes the increasing role of the CGA and geriatric assessment screening tools as well as their pertinent domains across various settings in the evaluation of the older adult with cancer who is considering cancer treatment.
AB - Geriatric assessments have now been recommended as part of the standard evaluation of an older adult considering cancer therapy. While the need for a more in-depth performance status evaluation of an older person with cancer was identified over 20 years ago, completion of a comprehensive geriatric assessment (CGA) is time-consuming and not frequently performed as part of the standard assessment of older cancer patients. Evidence suggests that incorporating such an evaluation could be useful for potentially determining the patient's chemotherapy tolerability or treatment completion, toxicity, and survival, as age alone has been shown to poorly predict treatment failure, and performance status assessments commonly used in oncology practice may lack predictability. This review describes the increasing role of the CGA and geriatric assessment screening tools as well as their pertinent domains across various settings in the evaluation of the older adult with cancer who is considering cancer treatment.
UR - http://www.scopus.com/inward/record.url?scp=85075576384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075576384&partnerID=8YFLogxK
M3 - Review article
C2 - 31769862
AN - SCOPUS:85075576384
SN - 0890-9091
VL - 33
SP - 458
EP - 466
JO - ONCOLOGY (United States)
JF - ONCOLOGY (United States)
IS - 11
ER -